Evidence map›Paper›PMID 36856433›Full record

ArticleAmerican journal of respiratory and critical care medicine2023

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary.

Alvar Agustí, Bartolome R Celli, Gerard J Criner, David Halpin, Antonio Anzueto, Peter Barnes, Jean Bourbeau, MeiLan K Han, Fernando J Martinez, Maria Montes de Oca and 11 more

2 registry-linked trialsAbstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 429 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
429citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07339280 naenrolling by invitationnot on this mapstarted 2026, after this paper: background citation

"The Effect of Probiotics on the Degree of Dyspnea, Lung Function, and Inflammatory Mediators in Patients With Chronic Obstructive Pulmonary Disease (COPD)."

TypeinterventionalSponsorUniversity Hospital of SplitRan2026 to 2030Enrolled60ConditionsCOPD, COPD (Chronic Obstructive Pulmonary Disease), Probiotic, Probiotic SupplementArmsProbiotic Capsule, placebo capsule
NCT07394712 narecruitingnot on this mapstarted 2025, after this paper: background citation

Comprehensive Maintenance Program: a Health Haven for COPD in Lleida.The NAPOLEON Project.

TypeinterventionalSponsorInstitut de Recerca Biomèdica de LleidaRan2025 to 2026Enrolled86ConditionsCOPD - Chronic Obstructive Pulmonary Disease, Pulmonary Rehabilitation, Randomised Controlled TrialArmsInterdisciplinary intervention
3 · Its place in the literature

Who cites it

429 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Observational
  20. Review

369 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Alvar AgustíUniv. Barcelona, Hospital Clinic, IDIBAPS and CIBERES, Spain.
Bartolome R CelliBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-7266-8371
Gerard J CrinerLewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
David HalpinUniversity of Exeter Medical School College of Medicine and Health, University of Exeter, Exeter, Devon, UK.ORCID 0000-0003-2009-4406
Antonio AnzuetoSouth Texas Veterans Health Care System, University of Texas Health, San Antonio, Texas, USA.
Peter BarnesNational Heart & Lung Institute, Imperial College London, United Kingdom.
Jean BourbeauMcGill University Health Centre, McGill University, Montreal, Canada.
MeiLan K HanUniversity of Michigan, Ann Arbor, Michigan, USA.
Fernando J MartinezWeill Cornell Medical Center/ New York-Presbyterian Hospital, New York, New York, USA.
Maria Montes de OcaHospital Universitario de Caracas Universidad Central de Venezuela Centro Médico de Caracas, Caracas, Venezuela.
Kevin MortimerLiverpool University Hospitals NHS Foundation Trust, UK / National Heart and Lung Institute, Imperial College, London, UK / School of Clinical Medicine, College of Health Sciences, University of Kwazulu-Natal, South Africa.
Alberto PapiUniversity of Ferrara, Ferrara, Italy.
Ian PavordRespiratory Medicine Unit and Oxford Respiratory NIHR Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, UK.
Nicolas RochePneumologie, Hôpital Cochin AP-HP.Centre, Université Paris, France.
Sundeep SalviPulmocare Research and Education (PURE) Foundation, Pune, India.
Don D SinSt. Paul's Hospital University of British Columbia, Vancouver, Canada.
Dave SinghUniversity of Manchester, Manchester, UK.
Robert StockleyUniversity Hospital, Birmingham, UK.
M Victorina López VarelaUniversidad de la República Hospital Maciel Montevideo, Uruguay; and.
Jadwiga A WedzichaNational Heart & Lung Institute, Imperial College London, United Kingdom.
Claus F VogelmeierDepartment of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University, German Center for Lung Research (DZL), Marburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Pulmonary Disease, Chronic ObstructiveHumansSeverity of Illness IndexSpirometry

Identifiers

PMID36856433
PMCPMC10111975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.